Symposium: Detection and management of lower UTI — the value of single dose therapy. Munich, 19 November 1988 K. G. Naber UTIs: An Overview Pages: S33 - S33
Urinary infection in the 1990's: The state of the art W. BrumfittJ. M. T. Hamilton-Miller UTIs: An Overview Pages: S34 - S39
The epidemiology of urinary tract infection and the concept of significant bacteriuria T. M. Hooton UTIs: An Overview Pages: S40 - S43
The optimal management of lower urinary tract infections L. E. Nicolle UTIs: An Overview Pages: S50 - S52
Review of published studies on single dose therapy of urinary tract infections R. R. Bailey UTIs: An Overview Pages: S53 - S56
Fosfomycin trometamol: Historical background and clinical development Giuliana Gialdroni Grassi Discussion 1 Fosfomycin Trometamol Preclinical Studies Pages: S57 - S59
Fosfomycin trometamol: Activity in vitro against urinary tract pathogens D. Greenwood Discussion 1 Fosfomycin Trometamol Preclinical Studies Pages: S60 - S64
Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity T. Bergan Discussion 1 Fosfomycin Trometamol Preclinical Studies Pages: S65 - S69
Fosfomycin trometamol versus ofloxacin/Co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: A multicentre study K. G. NaberU. Thyroff-Friesinger Discussion 2 Fosfomycin Trometamol International Clinical Studies Pages: S70 - S76
Single dose fosfomycin trometamol versus multiple dose norfloxacin over three days for uncomplicated UTI in general practice J. ReynaertD. Van EyckJ. Vandepitte Discussion 2 Fosfomycin Trometamol International Clinical Studies Pages: S77 - S79
Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice J. B. J. BoeremaF. Th. C. Willems Discussion 2 Fosfomycin Trometamol International Clinical Studies Pages: S80 - S88
A general practitioner multicenter study: Fosfomycin trometamol single dose versus pipemidic acid multiple dose A. Jardin Discussion 2 Fosfomycin Trometamol International Clinical Studies Pages: S89 - S93
Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: Preliminary results H. ThoumsinM. AghayanR. Lambotte Comparative Trials in Special Population Patients Pages: S94 - S97
Prophylactic chemotherapy with fosfomycin trometamol during transurethral surgery and urological manœuvres. Results of a multicentre study F. di SilverioG. FerroneL. Carati Comparative Trials in Special Population Patients Pages: S98 - S102
Prophylactic chemotherapy with fosfomycin trometamol versus placebo during transurethral prostatic resection L. BaertI. BillietJ. Vandepitte Comparative Trials in Special Population Patients Pages: S103 - S106
An open study of the efficacy and safety of single dose fosfomycin trometamol in treatment of hospitalised patients with urinary tract infection (pilot study) A. P. MacGowanR. A. BaileyD. S. Reeves Comparative Trials in Special Population Patients Pages: S107 - S108
Symposium: Detection and management of lower UTIs — The value of single dose therapy. Munich, 19 November 1988 K. G. Naber Summary Of Discussions And Closing Remarks Pages: S109 - S112